In contrast, hyperglycaemia causing mutations are located throughout the protein and most of them show a lower activity index, due to a reduction in substrate affinity combined or not with decreased catalytic turnover, which leads to an increased threshold for glucose-stimulated insulin release [9], [19]. The gene discussed is INS; the disease is Hyperglycemia.